Background: Angiotensin II type 1 (AT1) receptor blocker (ARB), telmisartan, is a widely used antihypertensive drug. It inhibits cancer cell proliferation, but the mechanisms by which telmisartan affects various cancers, including esophageal adenocarcinoma (EAC), remain unknown. Methods: The aim of the present study was to evaluate the antitumor effects of telmisartan on human EAC cell proliferation in vitro and in vivo. We studied the effects of telmisartan on human esophageal adenocarcinoma (EAC) cells using the cell lines OE19, OE33, and SKGT-4. Results: Telmisartan inhibited the proliferation in the EAC cell lines, OE19, OE33, and SKGT-4 in a time and dose-dependent manner. It induced cell-cycle arrest at the G 0 /G 1 phase, which was accompanied by an obvious activation of the AMP-activated kinase pathway and a decreased activation of mammalian target of rapamycin (mTOR) and p70S6 kinase. Telmisartan treatment led to remarkable decrease of cyclin D1, cyclin E, and other cellcycle-related proteins. In our in vivo study, intraperitoneal injection of telmisartan led to a remarkable reduction in tumor growth in mice bearing xenografts derived from the OE19 cells. Furthermore, miRNA expression was markedly altered by telmisartan in vitro and in vivo. Among these microRNAs, miR-301a-3p was significantly down-regulated, and it may regulate the phosphorylation of AMPKα through the AMPKα/mTOR signaling pathway to control cell proliferation in EAC cells. Conclusion: Telmisartan suppress human EAC cell proliferation and tumor growth by inducing cell-cycle arrest via the AMPK/mTOR pathway. Keywords: esophageal adenocarcinoma, angiotensin II type 1 receptor blockers, AT1, angiotensin II type 1, AMP-activated protein kinase, microRNA. Background: Esophageal squamous cell carcinoma (ESCC) develops within squamous epithelial layer and progressively invades into submucosal to subadventitial layers. Given that abundant adipose tissue exists in the subadventitia, adipose tissue seems critical for the progression of ESCC. However, their interaction is unknown. Aim: We aimed to address an interaction between ESCC and adipose tissue in vitro. Methods: ESCC cells (EC-GI-10 and TE-9) were cultured on rat or human subcutaneous adipose tissue-embedded or non-embedded collagen gel. Culture assembly was analyzed by electron microscopy, immunohistochemistry, Western blot, ELISA, and small-interfering RNA (siRNA) transfection, in terms of cell survival, growth, differentiation, and invasion. Results: Adipose tissue promoted the expression of the growth markers, Ki-67 antigen in the cancer cell types, whereas it inhibited that of the apoptosis marker, cleaved caspase-3. Adipose tissue accelerated the invasion of TE-9 cells into the gel, increased with matrix metalloproteinase (MMP)-9 in the culture medium. Adipose tissue promoted the expression of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase-AKT (PI3K-AKT) pathways and insulin-like growth factor-1 receptor (IGF-1R) in the cell types, while it decreased that of human epidermal growth factor receptor 2 (HER2). Cancer cell types in turn decreased IGF-1, adiponectin, leptin, and registin production in AT. IGF-1 promoted the growth of cancer cell types, while IGF-1R inhibitor (picropodophyllin) enhanced the apoptosis. TE-9 cells treated with IGF-1R siRNA transfection could not reproduce the adipose tissue-induced phenomena above. Moreover, ESCC cells inhibited the regeneration of adipose tissue. Conclusion: Adipose tissue may influence the progression of ESCC with the increased growth/invasion and the decreased apoptosis through IGF-1R upregulation. Adipose tissue may adversely affect the HER2-targeted therapy. ESCC cells may affect adipokine production of adipose tissue. We have shown for the first time that the strong interaction between ESCC cells and adipose tissue.
Background: Esophageal squamous cell carcinoma (ESCC) develops within squamous epithelial layer and progressively invades into submucosal to subadventitial layers. Given that abundant adipose tissue exists in the subadventitia, adipose tissue seems critical for the progression of ESCC. However, their interaction is unknown. Aim: We aimed to address an interaction between ESCC and adipose tissue in vitro. Methods: ESCC cells (EC-GI-10 and TE-9) were cultured on rat or human subcutaneous adipose tissue-embedded or non-embedded collagen gel. Culture assembly was analyzed by electron microscopy, immunohistochemistry, Western blot, ELISA, and small-interfering RNA (siRNA) transfection, in terms of cell survival, growth, differentiation, and invasion. Results: Adipose tissue promoted the expression of the growth markers, Ki-67 antigen in the cancer cell types, whereas it inhibited that of the apoptosis marker, cleaved caspase-3. Adipose tissue accelerated the invasion of TE-9 cells into the gel, increased with matrix metalloproteinase (MMP)-9 in the culture medium. Adipose tissue promoted the expression of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase-AKT (PI3K-AKT) pathways and insulin-like growth factor-1 receptor (IGF-1R) in the cell types, while it decreased that of human epidermal growth factor receptor 2 (HER2). Cancer cell types in turn decreased IGF-1, adiponectin, leptin, and registin production in AT. IGF-1 promoted the growth of cancer cell types, while IGF-1R inhibitor (picropodophyllin) enhanced the apoptosis. TE-9 cells treated with IGF-1R siRNA transfection could not reproduce the adipose tissue-induced phenomena above. Moreover, ESCC cells inhibited the regeneration of adipose tissue. Conclusion: Adipose tissue may influence the progression of ESCC with the increased growth/invasion and the decreased apoptosis through IGF-1R upregulation. Adipose tissue may adversely affect the HER2-targeted therapy. ESCC cells may affect adipokine production of adipose tissue. We have shown for the first time that the strong interaction between ESCC cells and adipose tissue.
# P-0116 A pilot study comparing first week initial clinical response to dual delayed-release dexlansoprazole 60 mg and esomeprazole 40 Background: Rapid onset of proton-pump inhibitors in achieving fast symptom relief is an unmet need for gastroesophageal reflux disease (GERD), but there is no report on short-term clinical response comparing dexlansoprazole 60 mg to esomeprazole 40 mg. This study aims to compare the 7-day clinical responses between the two drugs. Methods: We enrolled 175 adult GERD subjects, randomized them in 1:1 ratio to dexlansoprazole (n = 88) and esomeprazole (n = 87) for the intention-totreat analysis. Primary endpoints were complete symptom resolution rate (CSR) like heartburn, epigastric pain, or acid regurgitation in days 1, 3, and 7. Results: Thirteen patients were lost to follow up leaving 81 patients in each group for per-protocol analysis. At days 1, 3, and 7 post-dose, CSR for dexlansoprazole and esomeprazole was 25.9% vs. 28.4%, P = .724, 33.3% vs. 32.1%, P = .867, 51.9% vs. 48.1%, P = .637, respectively. In subgroup analysis, female patients attained higher CSR in dexlansoprazole group compared to esomeprazole group at day 3 (38.3% vs. 18.4%, P = .046) and an increase trend at day 7 (55.3% vs. 36.8%, P = .09). In esomeprazole group, female was a negative predictive factor for CSR in post-dose day 1 (OR, À1.249 ± 0.543; 95% CI: 0.287 [0.099-0.832], P = .022) and day 3 (OR, À1.254 ± 0.519; 95% CI: 0.285 [0.103-0.789], P = .016). Conclusion: This study suggested that symptom relief for GERD was higher in female patients who received single dose dexlansoprazole at day 3 and a trend of increased CSR at day 7.
# P-0211 Rumination syndrome in atypical gastro-oesophageal reflux diseases (GORD): The role of high-resolution manometry (HRM)-A case report from an Asian tertiary hospital (Singapore) Authors: ZHEN XI JOEL LEE; TZE WEI CHRISTOPHER CHIA Affiliation: Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore Background/Aim: Rumination syndrome (RS) is a functional gastroduodenal disorder of unknown etiology characterized by persistent or recurrent regurgitation of recently ingested food into the mouth, typically not preceded by retching and nausea. Difficulties in making the diagnosis may be caused by the lack of awareness of this entity among physicians and significant overlap with GORD symptoms. We highlight here a case of rumination syndrome in a middle-aged man who had been labeled chronically as refractory GORD in which HRM suggested an alternative diagnosis. Case Description: A 63-year-old man with a history of anxiety disorder was seen for reflux symptoms. History revealed persistent regurgitation symptoms for the past 15 years. He denied heartburn symptoms and had seen multiple physicians and was told to have GORD. His symptoms did not improve with proton-pump inhibitors (PPI) and dietary advice. He reported intermittent regurgitation of undigested food contents that did not taste acidic or sour. These episodes usually occurred within 10-15 minutes of food intake with eventual expulsion of the food contents. Gastroscopy revealed erosive esophagitis (Los Angeles Grade B). HRM was performed which showed several "R" wave consistent with RS that was characterized by simultaneous pressure waves arising from the gastric cavity (>30 mmHg) throughout the recording particularly during the multiple rapid swallows (water) and solid food challenge (biscuits). Thereafter, the patient was referred to the physiotherapist for diaphragmatic breathing. He was also given a short trial of PPI for 3 months for healing of the esophagitis seen. His symptoms improved dramatically. Conclusion: Rumination syndrome is an under-diagnosed condition in adults especially with symptoms suggestive of GORD. Careful history taking can suggest possible diagnosis. In cases of atypical GORD, role of HRM can help to clinch the diagnosis and alter further management.
# P-0212 Rare case of primary esophageal melanoma in a female-A case report from an Asian tertiary hospital (Singapore) Authors: ZHEN XI JOEL LEE; CHUNG KING CHIA Affiliation: Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore Background/Aim: Primary malignant melanoma of the esophagus is a rare and aggressive tumor. It has an incidence of 0.2% of all esophageal neoplasms. Up to 40.9% of patients have metastases at diagnosis.
1 Worldwide, less than 300 cases have been published with a male:female ratio of 2:1. There is no known risk factor for this malignancy.
2 Locally, there has been 3 case reports published thus far. [3] [4] [5] We highlight here a case of primary esophageal melanoma in an elderly female who presented with dysphagia. Case Description (Methods and Results): A 78-year-old lady was referred from the general practitioner to the gastroenterology clinic for progressive dysphagia of 3-month duration. She had complained of the sensation of food stuck in her "mid-chest" with loss of weight. She had a significant family history of malignancy in her siblings. Computed tomography (CT) of the thorax, abdomen, and pelvis showed a focal mural thickening in the mid-esophagus with no suspicious intra-abdominal mass seen. Gastroscopy revealed a nodule in the mid-esophagus. Multiple biopsies were taken. Histology of the esophageal nodule confirmed malignant melanoma with positive Melan A staining. Full skin survey was unremarkable. A body PET (positron emission tomography)/CT scan showed fludeoxyglucose (FDG) uptake in the upper-mid esophagus in keeping with the biopsy proven malignant melanoma. Endoscopy ultrasound showed a 16-mm submucosal lesion arising from the muscularis mucosae (MM) layer. There was no enlarged lymph node in the vicinity. Fine needle aspiration (FNA) confirmed malignant melanoma. Thereafter, the patient underwent a transhiatal esophagectomy. There were no post-operative complications, and she remains well. Conclusion: Having made a diagnosis of esophageal melanoma, one should always hunt meticulously for a primary lesion to exclude metastasis. A comprehensive history and physical examination is therefore mandatory. Early radical surgical excision offers the best survival outcomes.
References: Background: Esophageal adenocarcinoma (EAC) is a rising cancer. Longstanding inflammatory condition caused by gastroesophageal reflux induces Barrett esophagus (BE) and EAC. Rats underwent surgical procedure that causes the direct flow back of duodenal contents into the esophagus generate BE and EAC. We have investigated this surgically prepared rat carcinogenesis model. In first experiment, we made same model using mouse. We examined the difference of histological changes of mouse model compared with rat model. Second experiment was conducted to investigate the chemo-prevention effect for BE and EAC of parthenolide, a herbal nuclear factor (NF)-κB inhibitor. NF-kB involved in several steps of inflammatory and carcinogenic process. Methods: We operated fifty mice and fifteen rats to make carcinogenesis model. For second experiments, twenty of fifty mouse models take experimental chow containing parthenolide from one to forty weeks after surgery. Forty weeks after surgery, the resected esophagus of rodent models were evaluated histologically. Results: In first experiments, seventeen of thirty mice and twelve of fifteen rats were alive until forty weeks after surgery. The incidence of BE in mouse models and rat models was 71% (12/17) and 92% (11/12), respectively. The incidence of ADC in mouse models and rat models was 29% (5/17) and 75% (9/12), respectively. The histological changes were gentle and limited in small extent in mouse models compared with rat models. No metastases were found in both models. In second experiments, thirteen of twenty rats alive until forty weeks after surgery. The incidence of BE and ADC were 69% (9/13) and 15% (2/13) in mouse models with chow containing parthenolide. Conclusion: BE and ADC were induced in both of mouse and rat models. Parthenolide tended to suppress the expression of BE and ADC. Aim: In our previous study, microRNA(miR)-381 could enhance the radiosensitivity of ESCC cells. And miR-381 could be detected in both ESCC tissues and patients' serum. Circulating microRNAs have momentous clinical relevance as prognostic biomarkers and have been correlated with disease progression in many solid tumors. In further study, we try to evaluate the expression level of miR-381 and to investigate the potential usefulness of this molecule as a biomarker for prognosis in ESCC. Methods: Realtime PCR was performed to examine the amount of miR-381 in serum in ESCC patients and healthy controls. The prognostic implications of serum miR-381 level in human ESCC were further evaluated. Results: Expression levels of miR-381 in ESCC patients' serum were significantly lower than in healthy controls (P < 0.01). Moreover, lower serum miR-381 level more frequently occurred in ESCC patients with advanced tumor-nodemetastasis, advanced T and N stages (both P < 0.05), and poor tumor differentiation (P = 0.01). The Kaplan-Meier curve showed that lower miR-381 expression was closely associated with worse overall survival (OS) and disease-free survival (DFS) of patients with ESCC (both P < 0.01), and the serum level of miR-381 was found to be an independent prognostic factor for both OS and DFS (both P = 0.01) by further multivariate analysis. Conclusion: Decreased expression of miR-381 was closely associated with malignant progression and poor prognosis in ESCC patients. Therefore, the amount of miR-381 in serum may become a potential predictor for the clinical outcome of ESCC patients.
# P-0268 Comparison of treatment efficacy between vonoprazan and esomeprazole for improvement of symptoms in patients with erosive gastritis Authors: CHISE KANO; HIROSHI YAMASHITA; AKIHIKO OKADA Affiliation: Department of Gastroenterology and Hepatology, Osakafu Saiseikai Nakatsu Hospital, Osaka, Japan Background: Vonoprazan is reported to provide more potent and fastacting gastric acid suppressive effects compared with proton-pump inhibitors (PPIs). However, no data exist regarding the efficacy of vonoprazan for symptomatic improvement compared with PPIs. Methods: Patients with mucosal break diagnosed using endoscopy and reflux symptoms (heartburn or regurgitation) exceeding moderate grade defined according to the Global Overall Severity(GOS) scale were randomized to receive 20 mg of vonoprazan or esomeprazole. Patients were instructed to complete descriptive questionnaires every week for 4 weeks. The primary endpoint was comparing the percentage of patients in each treatment group achieving complete symptom relief during each week. Results: Following randomization, eleven patients received vonoprazan (mean age: 53.4, LA-AB/CD: 10/1), and 7 patients received esomeprazole (mean age: 62.8, LA-AB/CD: 6/1). The percentages of patients achieving complete symptom relief in vonoprazan and esomeprazole groups were 36.3 and 14.2 at 1 week (P = 0.63), 36.3 and 28.5 at 2 weeks (P = 0.86), and 54.5 and 28.5 at 3 weeks (P = 0.55), respectively. The percentages of patients achieving complete heartburn relief in the vonoprazan and esomeprazole groups were 36.3 and 14.2 at 1 week (P = 0.63), 36.3 and 28.5 at 2 weeks (P = 0.86), 54.5 and 28.5 at 3 weeks (P = 0.55), and 45.4 and 28.5 at 4 weeks (P = 0.82), respectively; percentages achieving complete regurgitation relief were 45.4 and 16.6 at 1 week (P = 0.51), 63.6 and 66.6 at 2 weeks (P = 0.68), 72.7 and 50.0 at 3 weeks (P = 0.94), and 54.5 and 83.3 at 4 weeks (P = 0.51). Conclusion: Vonoprazan treatment produced increased rates of complete symptom relief for both heartburn and regurgitation at 1 week. Therefore, vonoprazan treatment may be a useful strategy for early complete symptom relief. Background: SPAG5 was found as a prognostic biomarker in breast and cervical cancer, but its expression, clinic value, and function in esophageal squamous cell carcinoma (ESCC) was unclear. Methods: First, SPAG5 expression was analyzed in ESCC cell lines and tumor tissues. Then, its relationship with clinicopathological factors and survival were analyzed. Further, the effect of SPAG5 on cell proliferation, apoptosis, and metastasis was examined in vitro by modulating expression of SPAG5 through specific shRNA. Last, the potential mechanisms were also investigated by antibody microarray. Results: SPAG5 was up-regulated in ESCC, and expression of SPAG5 was correlated with tumor differentiation and lymph node metastasis. Univariate and multivariate analyses indicated that high SPAG5 expression might be a poor prognostic factor. Further studies demonstrated that inhibition of SPAG5 expression inhibited proliferation by inducing apoptosis and repressed invasion. Then, it was found that Rap1b shRNA decreased expression of proteins related to EMT and apoptosis pathways Conclusion: SPAG5 is a potential prognostic marker and promotes proliferation and invasion in ESCC. Background: In patients with advanced esophageal cancer involving thoracic aorta, aortoesophageal fistula is a rare complication but causes lethal hemorrhage. Efficacy of thoracic endovascular aortic repair (TEVAR) by handmade stent graft for aortoesophageal fistula is already reported. In 2008, commercially based stent graft was approved in Japan, and emergent or urgent TEVER for aortoesophageal fistula became possible. To investigate efficacy and safety of TEVAR for esophageal cancer with aortic invasion including aortoseohapgeal fistula, retrospective review was planned. Methods: We conducted retrospective chart review of the patients treated with TEVAR for advanced esophageal cancer with aortic invasion between April 2008 and December 2016 at Shonan Kamakura General Hospital. Efficacy and safety were analyzed. Results: Five cases were treated with TEVAR. Commercially available GORE® TAG® thoracic aortic stentgraft system was used in all cases. Two patients ware male, and 3 were female; median age was 75 years (67-76), and all the stages were UICC IIIC. Three cases were emergent for hematemesis, and 2 cases were prophylactic. Major complication of procedure was none. The median survival was 115 days (43-507); two cases were dead from intrathoracic or retroperitoneal hemorrhage from aortic rupture. One case was dead from disease progression, and other 2 cases were alive. Conclusion: For patients with advanced esophageal cancer involving aorta, it is possible to prevent hemorrhagic death from aortoesophageal fistula in a short term by TEVAR. The risk of stent-graft infection is high and may cause death from aortic rupture. Further study is needed for long-time survival.
# P-0319 Etiology and risk factors for gastroesophageal reflux disease and its subtypes: Results from a large cross-sectional study Background: Gastroesophageal reflux disease (GERD) can be divided into erosive reflux disease (ERD) and non-ERD (NERD) depending on the presence of mucosal damage in endoscopy. We evaluated the prevalence and risk factor of GERD and its subtypes in the Korean population.
Methods: Subjects who underwent upper gastrointestinal endoscopy for health screening from August 2015 to September 2016 were included. Prevalence, demographics, endoscopy results, and accompanying dyspepsia symptoms were retrospectively investigated in GERD subjects. This research has been approved by an ethical committee. Results: Of the total 10 607 subjects who underwent upper gastrointestinal endoscopy and symptom questionnaire, 729 (6.9%) had GERD: ERD (n = 315, 3.0%) and NERD (n = 414, 3.9%). Compared to subjects without reflux, number of male, BMI, and proportion of current smoker were significantly higher, and H. pylori infection rate was significantly lower in ERD group. On multivariate analysis, male, higher BMI, and negative H. pylori status were independent risk factors for ERD. In NERD group, number of male, level of education, and proportion of excessive alcohol consumers were lower than that of no reflux group. Multivariate analysis showed that the subjects in NERD group had significantly lower educational level and lower alcohol consumption. Overlap between GERD and functional dyspepsia was found in 20.6% of GERD subjects: The proportion of subjects with pure epigastric pain syndrome (EPS) was higher in both subgroups of GERD than in normal group, whereas that with pure postprandial distress syndrome (PDS) was higher only in NERD group. EPS-PDS overlap was more prevalent in ERD group. Conclusions: GERD is present in 6.9% of the Korean population. Male, higher BMI, and H. pylori negative status were associated with ERD. Lower education level and less alcohol consumption were related with NERD. There was considerable overlap between GERD and functional dyspepsia in the Korean general population.
# P-0335 Management of caustic consumption injuries-A multidisciplinary effort for a successful outcome Authors: BHARAT KUMAR NARA; T V ADITYA CHOWDARY; S THIRUNAVUKKARASU; K RAVINDRANATH Affiliation: Surgical Gastroenterology And Minimal Access Surgery, Gleaneagles Global Hospital Introduction: Ingestion of corrosive substances results in severe damage of upper aerodigestive system and is still a major cause of concern in India. Injuries depend on the type of substance, quality, quantity, and the intention. Corrosive agents produce extensive damage to gastrointestinal tract, which may result in death in the acute phase or may result in long-term sequelae. We describe the experience of our department in treating such injuries. Methods: All corrosive injury patients, acute and late, presented to the Department of Surgical Gastroenterology from January 2009 to June 2016, are included in this retrospective study. Results: Between January 2009 and June 2016, 55 patients were admitted with history of corrosive agent consumption. Twenty-three patients had only mild mucosal injury and were treated conservatively and required no further intervention. Three required emergency total gastrectomy with a cervical esophagostomy of whom only one survived. Twenty-four patients underwent repeated esophageal dilatations for strictures. One of them had a spontaneous duodenal perforation and succumbed. Seventeen patients responded very well to the dilatation protocol. Six patients underwent surgery for complication/failure of endoscopic dilatation. Five patients presented late with well-established strictures with poor nutrition and underwent a feeding jejunostomy with a reconstructive procedure at a later date. A total of 11 patients underwent a reconstructive procedure, 7 underwent a colonic pull through, and 4 underwent a Bilroth II distal gastrectomy. Conclusion: Corrosive injury of upper gastrointestinal tract is a complex condition, requiring an intensive approach and multidisciplinary management. Maintenance of nutrition is essential for a good outcome. The native esophagus should be salvaged whenever possible. Meticulous intra-operative technique and ensuring good vascular supply of the conduit are the cornerstones of successful outcome.
# P-0351 The sex-specific lag in incidence of symptomatic Barrett's esophagus-A UK prospective cohort study (EPIC-Norfolk) Background: The marked male predominance in patients with esophageal adenocarcinoma cannot be explained by known current risk factors. The lower incidence in women may be explained by a later age of onset of Barrett's esophagus due to the protective effects of premenopausal hormones. In laboratory studies, estrogen has demonstrated anti-inflammatory properties, which may prevent the inflammatory-driven metaplastic process associated with Barrett's disease. Aims: To investigate in a large prospective cohort study, the peak age of incidence of symptomatic Barrett's esophagus according to sex. Methods: A total of 30 445 men and women were recruited into the EPIC-Norfolk study between 1993 and 1997 and followed up until 2015 to identify incident cases of symptomatic Barrett's disease diagnosed using esophagogastroscopy. The crude sex-specific incidences were calculated according to age categories with 5-year cut-points and standardized (using the whole population) to calculate agestandardized incidence rates (ASRs). Results: Two hundred thirty-five participants developed Barrett's esophagus (68% men) during a mean followup of 17.6 years (SD 4.5), totalling 525 724 person-years. The peak incidence in men was at age 55-60 years (ASR 7.4/1000), whereas in women, it was 65-70 years (ASR 4.1/1000). In the 55-60 year category, the ASR ratio between men and women was 4:1, but equivalent (1:1) in the 65-70 year category, demonstrating an approximate 10-year disease lag in women. Conclusion: These findings are consistent with the hypothesis that high estrogen levels before the menopause may protect against Barrett's esophagus, creating a lag in female incidence. This may explain the striking gender difference in esophageal adenocarcinoma, where, due to the long duration of the metaplastic-dysplastic sequence, women are likely die from other competing causes before the onset of esophageal cancer. Further evaluation of the potential protective effects of estrogen against esophageal adenocarcinoma is warranted. Background: Physical activity affects the functioning of the gastrointestinal system through both local and systemic effects and may play an important role in reducing the risk of developing esophageal adenocarcinoma. This review assesses the epidemiological evidence for the relationship between physical activity and the development of gastroesophageal reflux disease (GORD), Barrett's esophagus, and esophageal adenocarcinoma. Methods: A search of PubMed, Medline, Embase, and CINHAL was conducted from their inceptions to March 25, 2017, for observational studies that examined associations between recreational and/or occupational levels of physical activity and the risk of GORD, Barrett's esophagus, and esophageal adenocarcinoma. Furthermore, GORD was examined using a meta-analysis. Results: Seven studies were included (2 cohort and 5 case-control). For GORD, there were 3 case-control studies with 10 200 cases among 78 034 participants, with a pooled estimated OR of 0.67 (95% CI 0.57-0.78) for high vs. low levels of recreational physical activity. In Barrett's esophagus, there was a single case-control study, which reported no association, OR 1.19 (95% CI 0.81-1.73). For esophageal adenocarcinoma, there were 3 studies (2 prospective cohort and 1 case control) with 666 cases among 910 376 participants. The largest cohort study reported an inverse association for high vs. low levels of recreational physical activity, RR 0.68, 95% CI 0.48-0.96. The remaining studies reported no associations with either occupational or combined recreational and occupational activity. Heterogeneity in the measurement of exposure (recreational, occupational, and both) made a pooled estimate for esophageal adenocarcinoma inappropriate. Conclusion: Although limited, there is some evidence that higher levels of recreational physical activity may reduce the risk of both GORD and esophageal adenocarcinoma, but further large cohort studies examining the type, intensity, and duration of activities that may be beneficial are needed.
# P-0354 Normative Chicago 3.0 metrics for high-resolution esophageal manometry (InSIGHT ultima®) Background: The study of esophageal function has significant advancement with availability of high-resolution manometry (HRM). We aimed to determine normative metrics among healthy Malay volunteers and to evaluate effects of provocative swallows in various positions. Method: We conducted a cross-sectional study of 50 healthy Malay adult volunteers using the InSIGHT Ultima® system (Diversatek, Highlands Ranch, USA). HRM metrics (95 percentile) were analyzed using the Chicago Classification version 3.0 following completion of swallowing protocols consisting of liquid, viscous, and solid materials in recumbent and standing positions. Result: Normative metrics in the recumbent position for integrated relaxation pressure (IRP) 4 s, distal contractile integral (DCI), distal latency (DL), and length of peristaltic break (PB) were 17 mmHg (median 9, range 7-12), 2633 mmHg s À1 cm À1 (median 856, range 501-1525), 8.5 s (median 6.4, range 5.7-7.3), and 7 cm (median 2, range 0-3), respectively. Significant delay of DL was observed with viscous vs. liquid swallows (median 7.5 s vs. 6.4 s, P < 0.01). More distinctive changes in metrics were observed with solid materials vs. liquid swallows including increment of DCI (median 1098 vs. 856, P < 0.05), prolonged DL (median 8.2 vs. 6.4 s, P < 0.01) but shorter breaks (median 0 vs. 1.4 cm, P < 0.01).
Shifting from recumbent to standing position caused a significant reduction in IRP 4 s (median 9 vs. 7 mmHg, P < 0.05) but not with other metrics. In standing position, a significant delay of DL was observed with solid vs. viscous swallows (median 8.0 vs. 7.5 s, P < 0.01). Background: Achalasia is a rare esophageal motility disorder with debilitating symptoms that can impact on a patient's quality of life. Conventional treatments include graded PD or laparoscopic Heller myotomy (LHM). Patients who undergo PD may be subjected to repeated dilations to achieve symptom control. In this study, we looked at the number of pneumatic dilations and balloon size required to achieve symptom control in a group of Asian patients with achalasia. We also looked at patients who had undergone LHM and their symptoms post-surgery. Methods: In this retrospective pilot study, a total of 11 Asian patients with achalasia diagnosed by high resolution manometry (HRM) were studied. Symptoms were assessed by using the Eckardt scores pre-and post-intervention. Treatment was considered successful if the Eckardt score was 3 or less. Patients were followed up for at least 9 months. Results: Of the 11 patients, 27% had Type I achalasia with mean integrated relaxation pressure (IRP) of 27.2 mmHg, and 73% had Type II achalasia with a mean IRP of 22.9 mmHg. There were none with Type III achalasia. Seventy-eight percent who underwent PD had successful treatment after just one session. Three of these patients had Type 1 achalasia, and 4 of these patients had Type 2 achalasia. All of the dilations were performed using a 30-mm balloon size. Of the 2 patients with suboptimal treatment response to PD, one previously had a LHM with subsequent recurrence of symptoms after 2 years, and the other defaulted follow-up. In our cohort, only 3 patients underwent LHM, of which 67% had good response to treatment post-surgery. Conclusion: Our findings show that in a cohort of Asian patients with achalasia, one session of PD using a 30-mm balloon is sufficient to achieve a good treatment response without undergoing the conventional graded dilator approach.
# (MMS, The Netherlands) with pH sensor 5 cm above lower esophageal sphincter (LES). Snacks (two burgers and 250-mL drink) were given at 10:00 PM for two nights. Participants were randomized to single administration of either Gaviscon Advance or antacid in an open-label fashion on the second night, 10 min after snacks. The pH at cardia and 5 cm above LES, frequency of acid refluxes (pH < 4), and symptoms were measured every 10 min after supper for 1 h. Results: (Fig. ) Eighteen participants (mean age 33.5 and BMI 32.8 kg/m 2 ) entered the trial, with nine participants each group. Significant pH suppression of acid pocket was observed with Gaviscon Advance vs. antacid (median pH difference 2.7, P = 0.008). The frequency of acid refluxes was also less after Gaviscon Advance vs. antacid (median difference 2.2, P = 0.03), although no significant difference in pH of GER was observed between the two groups. Symptoms (heartburn and regurgitation) were not different between the two groups (all P > 0.05). Conclusion: Gaviscon Advance is more efficacious than antacid in post-supper suppression of acid pocket and frequency of GER with similar pH suppression of GER and symptoms in obesity. Introduction: Spontaneous esophageal rupture (Boerhaave syndrome) is rare and has a highly mortality rate. Late diagnosis and treatment can be fatal. Presentation of Case: The patient was a 48-year-old male who had vomited and developed chest pain after drinking alcohol. He was transferred to our hospital 12 hours after the symptoms occurred. The chest pain was exacerbated by deep breathing. He had a fever with a body temperature (BT) of 38.1°C, and his oxygen saturation level was 94% (in room air). His blood pressure was stable. His white blood cell count and Creactive protein level were slightly abnormal. Computed tomography (CT) showed mediastinal emphysema and that the left wall of the lower esophagus had ruptured. Contrast-enhanced esophagography revealed the leakage of contrast media into the mediastinum, but the media did not pass into the intrathoracic cavity. The patient was diagnosed with spontaneous esophageal rupture. Conservative therapy, involving intravenous broadspectrum antibiotics, an intravenous proton pump inhibitor, nasogastric tube drainage, and total parenteral nutrition, was administered. The patient's physical improved, and his BT dropped below 37°C. On postoperative day (POD) 15, follow-up contrast-enhanced esophagography showed no leakage of contrast media. However, CT revealed an abscess near to the left side of the lower esophagus. After confirming that the abscess had reduced in size, oral intake was started on POD 22. The patient was discharged from hospital on POD 39. Conclusion: We experienced a case of spontaneous esophageal rupture (Boerhaave syndrome) that was successfully treated with conservative treatment. Background: Even if concurrent chemo-radiotherapy (CCRT) is one of treatment modality for localized advanced or advanced esophageal cancer, prediction factors of CCRT response have been limited. Primary threedimensional (3D) cultured cells have evident advantages in providing more physiologically relevant and predictive data for in vivo tests. Method: Primary 3D cell culture (spheroid) was performed using tumor tissues acquired from esophageal cancer before 1st CCRT. After 7 days cultured, same-sized spheroids were collected and were treated with 5-FU, and 5-Gy radiotherapy was provided. After 6 days, primary cultured cells were stained, and fluorescent images were captured. Clinical response was assessed before 5th cycle CCRT. Clinical response was classified as complete remission (CR), partial remission (PR), and disease progression (PD).
Results: A total of 17 esophageal cancer patients were enrolled. Final success rate of primary 3D cell culture was 76% (13/17). A total of 10 persons were followed up more than 4 cycles of CCRT and were analyzed. Clinical CR was observed in 6 persons, and two persons showed clinical PR (n = 3) or PD (n = 1). Table 1 . In healthy Malays, refluxes were predominantly weakly acidic (n = 1517) but also higher occurrence of weakly alkaline refluxes (n = 203). Conclusion: We establish normative values for 24-hour ambulatory MII-pH monitoring with the ZepHr system in the Malay population. (ACF) or docetaxel, cisplatin, and 5-fluorouracil (DCF) followed by surgical resection in our hospital were retrospectively investigated. We analyzed the association between NLR of both pre-and post-NAC and side effects, response to chemotherapy, and overall survival (OS). Results: One hundred seventeen patients were male, and 18 patients were female. The median age was 67 (range 35-83). Seventy and 65 patients received ACF and DCF, respectively. The median NLR of pre-NAC was 2.7(range 0.9-12.7) and that of post-NAC was 2.1 (range 0.5-11.4). NLR of both pre-and post-NAC was not associated with side effects and response. OS of patients with higher NLR of post-NAC (>3.0, n = 31) was significantly poorer than that of patients with lower NLR (<3.0, n = 104) (P = 0.01). Conclusion: NLR after chemotherapy may have a better prognostic value for patients with ESCC undergoing NAC. Introduction: Acute variceal bleeding is a life-threatening complication among cirrhotic patient. Endoscopic band ligation and vasoactive medications are the mainstay treatment for active variceal bleeding. However, Sengstaken-Blakemore (SB) tube indwelling serves as an effective temporizing measure used in hemostasis of variceal bleeding when primary therapies fail. Yet, it has some complications with esophageal rupture as the most lethal one. Case Description: A 60-year-old man with hepatitis C cirrhosis was scheduled for elective ligation of esophageal varices after his recent acute variceal bleeding. Four esophageal varices of one form 2 and three form 1 with red whale sign were found endoscopically. When performing variceal ligation, one active oozing bleeding was seen from one of the ligated varices during the procedure. Further attempted ligations failed to achieve hemostasis. SB tube was subsequently applied. Patient had a prominent acute sharp pain when the gastric balloon of SB tube was being inflated. Chest roentgenogram reconfirmation was made after the procedure, and an ovoid shape balloon was seen above diaphragm ( Fig. 1) . Malposition of gastric balloon at esophagus was highly suspected. Therefore, immediate deflation with readjustment of SB tube position was performed. Patient was seen to have a drastic relief of pain. Another episode of persistent epigastric pain accompanied with subcutaneous emphysema occurred in the next day. Computed tomography of chest further uncovered esophageal rupture with pneumo-mediastinum. Family opted for conservative treatment when surgical intervention was suggested. Patient expired 1 week later after an episode of massive hematemesis in intensive care unit.
not yet been validated. Moreover, its ideal cut-off value in determining GERD in the Korean population has not been clearly defined. Therefore, we aimed to assess the diagnostic accuracy of the Korean version of GerdQ and to its reproducibility and concurrent validity. Methods: After repeated translations and backward translations, the Korean version of GerdQ was prepared. Patients with symptoms suggestive of GERD were asked to answer to the GerdQ at their first visit. A second GerdQ questionnaire was then administered to the patients when they visited for their subsequent appointment for upper endoscopy, which was at least 2 weeks after the first visit. The final questionnaire was provided after proton pump inhibitor (PPI) treatment. Reflux esophagitis or pathological acid exposure was used as diagnostic references for GERD. The diagnostic accuracy of the GerdQ for GERD with regard to symptom response to PPI therapy was assessed.
Results: A total of 149 patients (52 male and 97 female) with a mean age of 52.6 ± 14.6 years were enrolled. A GerdQ cutoff of 7 was found to the best balance with regard to sensitivity (64.6% [95% CI: 55. Background: This phase 4 study, sponsored by Takeda, evaluated the efficacy and safety of dexlansoprazole MR (modified release), a dual delayed-release formulation, in Asian subjects with non-erosive reflux disease (NERD) and erosive esophagitis (EE). Methods: Subjects aged ≥20 years with persistent typical GERD symptoms for at least 6 months underwent endoscopy. Based on endoscopic findings, they were randomly assigned to either dexlansoprazole MR 30 mg once daily (QD) for 4 weeks (NERD group) or dexlansoprazole MR 60 mg QD for 8 weeks (EE group). The primary endpoint was the percentage of days that subjects did not experience any 24-hour heartburn or acid regurgitation. Results: Four hundred forty-five subjects were screened from Hong Kong, South Korea, and Taiwan, of whom 208 were enrolled in the NERD group (mean age: 53.6 years, male: 34.6%) and 88 in the EE group (mean age: 51.7 years, male: 55.7%). Over the treatment period, the median percentage of days that subjects did not experience any 24-hour heartburn or acid regurgitation was 26.92% and 65.45% in the NERD and EE groups, respectively. The median percentage of days that subjects did not experience any nighttime heartburn or acid regurgitation in the NERD and EE groups was 59.26% and 83.33%, respectively (Table ) . The treatment was well tolerated with low incidence of adverse events (AEs) related to study drug in NERD and EE groups-6.7% and 5.7%, respectively. Conclusions: In Asian patients with GERD, treatment with dexlansoprazole MR indicated a favorable efficacy and safety profile in relieving heartburn and acid regurgitation symptoms.
# P-0703 Spectrum of esophageal motility disorders using high-resolution manometry at a tertiary referral center Authors: VINOD GUPTA; RAJIV BAIJAL; RAKESH TANDON Affiliation: Pushpawati Singhania Research Institute (PSRI) and Hospital, New Delhi, India
Background: Esophageal motility disorders are attributable to neuromuscular dysfunction of the esophagus, presenting as dysphagia, chest pain, or heartburn. We aimed to study the clinical and manometric profile of esophageal motility disorders and to identify the various etiologies of motor dysphagia at our center. Methods: This study was a prospective crosssectional study done at PSRI Hospital. Adult patients with motor dysphagia referred to the GI Motility Laboratory from 2015 to 2017 were analyzed. All patients were evaluated for symptoms such as dysphagia, regurgitation, chest pain, heartburn, bolus obstruction, globus sensation, respiratory symptoms, and weight loss. Eckardt scoring was done for achalasia. High-resolution manometry was done in supine position using 16-channel Table 1 Data water perfusion system (model: KANGAROOJEF). Basal LES pressure was recorded for 1 minute. Esophageal peristalsis was recorded for ten swallows of 5 ml water each. Analysis was done using Chicago classification version 3. Results: One hundred seventeen patients formed the study group (mean age 43.7 years, 34% females). The main symptoms at presentation were dysphagia (44, 37.6%), regurgitation (31, 26.4%), weight loss (8, 6.8%), chest pain (15, 12.8%), vomiting (7, 5.9%), and retrosternal burning (10, 8.5%). The manometric profile showed the following abnormalities: achalasia cardia (24 cases [Type I-2, Type II-7, and Type III -15], 20.5%) with mean Eckardt score of 4.79 (range 1-6), ineffective esophageal motility (23, 19.6%), distal esophageal spasm (3, 2.5%), hypertensive peristalsis (2, 1.7%), and esophago-gastric junction outflow obstruction (3, 2.5%). Conclusion: In this study, achalasia cardia was the most common cause of motor dysphagia followed closely by ineffective esophageal motility. Type III was the most common type of achalasia.
# P-0721 Wireless electrical stimulation for managing gastroesophageal reflux disease in the rabbit model Authors: MIN WANG; LILI ZHAO; ZHINING FAN Background and Aim: Electrical stimulation of lower esophageal sphincter (LES) has been approved to increase LES pressure (LESP) and commercially treat gastroesophageal reflux disease (GERD). Endostim ™ -like active appliance was efficient but needs reoperation for replacing the battery part. Therefore, one novel passive LES stimulation system was invented and evaluated here in rabbits. Methods: Different from Endostim ™ , wireless power technology was firstly applied in the implanted part. The LES stimulation could be easily self-controlled and powered by external system. No need for reoperation or implantation replacement. In order to evaluate its efficacy and safety, GERD rabbit model was created by balloon dilation and applied to optimize stimulating parameters. Body weight, food intake, and LESP were recorded in the experimental course. Results: A total of 12 rabbits (male, 3-4 kg) were successfully applied for equipment implantation. LES stimulation was delivered at 20 Hz, 215 μs, and 3-8 mA in multiple 30-minute sessions. The muscle contraction phenomenon was obviously observed during the surgery in the stimulation group (6 rabbits). The mean LESP was increased significantly in stimulation group than sham group (stimulation group: 9.25 ± 1.24 mmHg vs 13.99 ± 1.28 mmHg, P < 0.05; sham control group: 9.00 ± 1.22 mmHg vs 9.23 ± 1.27 mmHg, P = 0.267). After operation, the body weight initially decreased but recovered after 1 week. No serious implantation or stimulation-related adverse effects were reported in the 2-month follow-up. Conclusion: Electric stimulation represents the perspective approach for treating GERD in clinics. This novel wireless LES stimulation system was also safe and effective for treating GERD rabbits. After implantation, its passive medical strategy will benefit patients and keep the long-term efficacy for clinical GERD management. Background: Reduced insulin sensitivity or insulin resistance may manifest as metabolic syndrome that carries a high risk for cardiovascular events. Although controversial, insulin resistance had been reported to have a significant relationship to the severity of gastroesophageal reflux disease (GERD). Differences in subjects' characteristics and measurement used in previous studies encourage the need to assign the study in Indonesia to set a better prevention towards metabolic syndrome and management of GERD. Aim: To learn the association between the severity of gastroesophageal reflux disease and insulin sensitivity. Methods: We conducted a cross-sectional study of 84 adult patients with GERD symptoms. The subjects were recruited consecutively between January 2017 and April 2017 at Cipto Mangunkusumo National Hospital in Jakarta. GERDQ questionnaire was used for subject recruitment. Homeostatic model assessment insulin resistance (HOMA-IR) index was used to evaluate insulin sensitivity. Esophageal erosions were diagnosed using upper gastrointestinal endoscopy. Results: The median of HOMA-IR in all subjects was 1.46 (0.32-13.85) . Through endoscopic examination, we found that 48 (57.1%) people did not have esophageal erosion and the other 36 (42.9%) people had erosive esophagitis. Using Mann-Whitney test, we found that the erosive esophagitis was associated with lower insulin sensitivity (P = 0.015). HOMA-IR index was higher in esophagitis patients than in non-erosive patients, with the median of 1.74 (0.35-13.85 ) and 1.21 (0.32-10.78), respectively. Conclusion: The severity of GERD, based on esophageal erosion, is negatively associated with insulin sensitivity. Keywords GERD severity, insulin sensitivity, HOMA-IR. Details of H&N cancer were as follows: oral 1/oropharyngeal 4/hypopharyngeal 9/larynx 4 cases and stage II 2/III 7/IV 9 cases. Regarding CRT, radiation therapy of 66 to 70 Gy was performed only for H&N region concurrently with chemotherapy (docetaxel alone, 1; docetaxel plus cisplatin, 17 (5 cases additionally received TPF [combination of docetaxel, cisplatin, and 5-FU] therapy). The initial average tumor size of EC was 30 (range 10-80) mm, and the initial invasion depth was EP-LPM 13/MM-SM1 3/SM2 or deeper 4. On endoscopic examination conducted after median 4 (range 0-7) months after CRT, 4 EC lesions disappeared (originally EP-LPM: 3; SM2: 1), and 5 lesions had shrunk (originally EP-LPM: 3; MM-SM1: 1; SM2: 1; and invasion depth of all lesions became EP-LPM). The other 11 lesions were stable with no progression. Endoscopic submucosal dissection for 11 lesions, CRT for 3 lesions, and surgery for 2 lesions were performed. Conclusion: Subsequent treatment against superficial EC after CRT for H&N cancer is considered a reasonable management. Chemotherapy for H&N cancer was effective for 45% of synchronous superficial EC. Introduction: Dysphagia is a known complication of dermatomyositis during the course of the disease, usually attributed to muscular involvement. We report a case of a patient with dermatomyositis who developed life-threatening sudden onset dysphagia as an early manifestation of disease and showed a delayed response to intravenous immunoglobulins and rehabilitation therapy. Case report: At 1 month after diagnosing dermatomyositis and starting treatment, a 53-year-old male complained of a sudden inability to swallow solid foods, liquids, and even saliva. A computed tomography scan of the larynx, an esophagogastroduodenoscopy, and brain magnetic resonance imaging was unremarkable. A videofluoroscopic swallowing study revealed inadequate pharyngeal contraction with aspiration. Decreased upper esophageal sphincter relaxation was observed, but it was not a direct cause of dysphagia but a secondary change due to decreased contraction of the pharynx. Treatment with methylprednisolone failed, and therapy with IVIG was applied. At 6 weeks after IVIG therapy, he could swallow saliva again. At 4 months from the onset of dysphagia, he showed normal swallowing function. During the course of medical treatment for life-threatening dysphagia, he continued with rehabilitative dysphagia therapy. Conclusion: A dermatomyositis patient with acute onset life-threatening dysphagia recovered after 4 months with extensive medical and rehabilitation support, and dysphagia did not recur for subsequent 2 years. Intractable acute oropharyngeal dysphagia in myopathy can be reversible.
# P-0835 Construction of esophageal squamous cell carcinoma-specific transcriptional regulatory networks revealed co-activation of four genes Authors: LI MIN; YU ZHAO; SHENGTAO ZHU; SHUILONG GUO; SHUTIAN ZHANG Affiliation: Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing, 100050, P. R. China
Background: Many studies revealed genetic and molecular characteristics of esophageal squamous cell carcinoma (ESCC). However, studies systematically investigated transcriptional regulatory network of ESCC are absent. Methods: Using paired ESCC and adjacent normal tissues (NC), we evaluated expression level of all genes by microarray assays. Then we integrated motif data of transcription factors (TFs) in JASPAR database and constructed networks between TFs and their targets by Passing Attributes between Networks for Data Assimilation (PANDA) method. Hypergeometric distribution model was applied to analyze target profile similarity and find co-activation effects using both TF-targets networks data and different expression data. Expression level of four co-targeted genes was also validated by qPCR. Results: We identified 1116 upregulated genes and 1301 down-regulated genes in ESCC compared with NC. Additionally, we identified 16 970 ESCC-specific edges and 9307 NC-specific edges in TF-targets regulatory networks. Among all 131 TFs included in this study, 17 were found repressed and 5 were found activated in ESCC. We revealed that 16 genes were co-targeted by 4 TFs (SPIB, MZF1, MAFG, and NFE2L1) in ESCC, among which ENO2, MPO, NDST1, and CDH9 were validated by qPCR in an independent ESCC cohort. Conclusions: We constructed TF-targets regulatory networks in both ESCC and NC tissues and found SPIB, MZF1, MAFG, and NFE2L1 coactivated in ESCC. Our findings would give a distinctive insight into studies of ESCC carcinogenesis mechanism. Background: There has been an increasing incidence of HIV-infected individuals worldwide and locally. Along with its increasing number, there is also an increasing incidence of HIV-related infections or illnesses such as cytomegalovirus (CMV) and varicella zoster virus (VZV). Objective: This paper aims to present a case of a 36-year-old Filipino male presenting with a chief complaint of difficulty of breathing. Discussion: This patient has been treated as having atypical pneumonia and fungal infection, but still had worsening of symptoms. An upper endoscopy with biopsy was done showing esophageal lesions that is grossly similar with lesions of CMV esophagitis. However, biopsy results showed otherwise. The patient has been diagnosed with idiopathic esophagitis, which is a diagnosis of exclusion and can mimic other esophageal infections. The etiology for idiopathic esophagitis is still uncertain, but it can be attributed to high viremia, inflammatory cytokines, and altered GI immunopathophysiology. Treatment involves the use of prednisone and anti-retroviral therapy. Conclusion: Among patients with esophagitis not responding to therapy, an endoscopy with biopsy can be done to help in the diagnosis and proper treatment.
# P-0994 Effects of mosapride in patients with minor disorders of esophageal peristalsis using high-resolution manometry Background/Aims: Minor disorders of peristalsis are frequently observed esophageal motility, which may be shown dysphagia or reflux symptoms. Unfortunately, therapeutic options for minor peristaltic disorders are limited, and the role of prokinetics has been controversial so far. This study investigated the efficacy of mosapride in patients with minor peristaltic disorders. Methods: A total of 10 patients with esophageal symptoms, who were diagnosed as minor disorders of peristalsis by gastroscopy and high-resolution manometry (HRM) using the Chicago Classification v3.0, were prospectively enrolled. Patients received mosapride 30 mg daily for 2 weeks. Symptoms assessment including abbreviated version of the World Health Organization quality of life scale (WHOQOL-BREF) and the HRM study was performed before treatment and after 2 weeks. Results: Complete response (≥80%), satisfactory response (≥50%), partial response (<50%), and refractory response rates were 20.0%, 60.0%, 10.0%, and 10.0%, respectively. Overall response rate (complete + satisfactory) was 80.0%, and overall score of WHOQOL-BREF was significantly increased after treatment (6.2 ± 1.1 to 6.9 ± 1.1, P = 0.025). In the HRM metrics, lower esophageal sphincter (LES) respiratory mean pressure was significantly increased after treatment (13.5 ± 8.4 mmHg to 17.0 ± 8.7 mmHg, P = 0.014). The values of LES length, LES residual pressure, effective swallows, and distal contractile integral were increased after treatment; however, there was no significant difference before and after treatment. Conclusions: Mosapride improved overall symptoms and increased LES respiratory mean pressure with presenting a tendency to increase LES contraction and esophageal motility in patients with minor peristaltic disorders. However, further large-scale studies are needed to identify the effect of mosapride. Key words: Esophageal motility disorders; High-resolution manometry; Mosapride; Esophageal sphincter, lower; Symptom assessment. Background: Major complications after esophagectomy include anastomotic leak, ischemic conduit, conduit mal-rotation, and delayed gastric emptying. Accurate and timely detection of complications is challenging. Upper endoscopy is increasingly used to detect and manage complications. This study looks into the indications, timing, and accuracy of early postoperative upper endoscopy in the diagnosis of the above complications. Different endoscopic therapeutic procedures were also investigated. Method: Records of all patients who underwent esophagectomy between January 2014 and December 2016 in a tertiary referral center were reviewed. Early post-operative upper endoscopy was defined as upper endoscopy performed within the same admission. Results: A total of 114 patients underwent esophagectomy. Forty-four patients (38.6%) had early post-operative upper endoscopy. The most common indications were atrial fibrillation (33.3%), sinus tachycardia (17.9%), and fever (17.9%). Fifteen out of these 44 patients (34.1%) had abnormal findings. Upper endoscopy detected 7 anastomotic leaks *(Sn: 70.0%, Sp: 100%, PPV: 100%, and NPV: 92.3%), 3 ischemic conduits *(Sn: 100%, Sp: 100%, PPV 100%, and NPV 100%), 2 conduit mal-rotation, and 3 delayed gastric emptying. Contrast study and computed tomography had inferior sensitivity and specificity for anastomotic leaks. No complications from endoscopy were reported. The post-operative day of diagnosis of ischemic conduit was on days 1, 2, and 5. The median post-operative day for diagnosis of anastomotic leak was 9.5 (4-27). Feeding tube/decompression tube insertion (n = 20) and stenting (n = 3) were the most performed endoscopic therapeutic procedures. There was no in-hospital mortality. The two patients who had conduit malrotation required re-exploration, while the three with delayed gastric emptying were treated conservatively. Conclusion: Early post-operative upper endoscopy is safe, sensitive, and specific in the diagnosis of anastomotic leak and ischemic conduit. Appropriate timing and careful case selection may reduce unnecessary endoscopies. *Sn = sensitivity; Sp = specificity; PPV = positive predictive value; NPV = negative predictive value. Background: The N-methyl-D-aspartate receptor (NMDAR) and D-serine may mediate the neural plasticity, which may develop following nociceptive emotional experience in prefrontal cortex (PFC) and hippocampus. However, whether the neural plasticity participates in the mechanism of esophageal visceral hypersensitivity is little known. Therefore, we aimed to investigate the neural molecular alterations after acid exposure. Methods: All rats were exposed to esophageal acid or saline at postnatal days 7-15 (P7), and most rats underwent acute exposure again at adult time (P60). All rats were randomly distributed to 5 groups, including P7S, P7H, P7H + P60H, P7H + P60S, P7S + P60H (H: 0.1 N HCL infusion; S: saline). The tissue harvest was conducted at P60. We examined the expression of NMDAR subunits, c-fos, serine racemase (SR) and D-serine in PFC, dorsal (DH), and ventral hippocampus (VH). Results: In PFC, compared with adult saline treatment (AS: P7H + P60H and P7S + P60H group) and without adult treatment(AÀ: P7S and P7H group), adult acid exposure (AH) increased the expression of NR1 (P = 0.052, P = 0.298), NR2B (P = 0.035, P = 0.045), and SR (P = 0.022, P = 0.017) significantly. In VH, compared with AÀ, AH caused increasing expression of NR2B (P = 0.012) and NR1 (P = 0.024) significantly. In PFC, the expression of SR in the P7S + P60H group was obviously higher than that of other groups (P = 0.008). In DH, there was statistical significance on the level of c-fos between the P7S + P60H group and other groups (P = 0.008). In PFC, the LC-MS analysis results that D-serine decreased in AH (P = 0.000) and AS (P = 0.042) group, comparing with AÀ group. Conclusion: Those long-term and transitional molecular alterations in PFC and hippocampus may mediate the development of acid exposure related esophageal visceral hypersensitivity.
# P-1050 The psychological characteristics of reflux hypersensitivity-A pilot study based on SCL-90 questionnaire and 24-h pH-impedance monitoring Authors: KUN WANG; ZHIJIE XU; YING GE; ZHIWEI XIA; KUNLUN WANG; LIPING DUAN Affiliation: Department Of Gastroenterology, Peking University Third Hospital Aims: Reflux hypersensitivity (RHV) was lately defined by Rome IV workshop. The aim of this study was to assess the psychological characteristics of RHV. Methods: Patients who underwent 24-h pH-impedance monitoring were screened from January 1, 2011 to November 31, 2015. Patients with heartburn or chest pain ≥2 days/week for more than 6 months were enrolled. All subjects fulfilled the SCL-90 questionnaire, underwent gastroscopy, and underwent HRM test to exclude organic diseases of main motility disorders. The patients were diagnosed respectively as non-erosive reflux disease (NERD), functional heartburn (FH), and RHV according to ROME IV criteria. Results: Two-hundred thirty-one patients were enrolled including NERD (48.25 ± 1.18 years, M:F = 55:52), 92 FH (48.30 ± 1.27 years, M:F = 9:83), and 32 RHV (48.41 ± 2.36 years, M: F = 4:28). Twenty-eight HVs (47.21 ± 2.27, M:F = 8:20) were enrolled as controls. NERD presented higher acid exposure time (pH > 4.2) than those of FH, RHV, and HV. The acid reflux and weakly acid reflux were both higher in NERD than that in FH, RHV, and HV (P < 0.001). The total scores of SCL-90 of each group of patients were significantly higher than HV (NERD:HV, 133.15 ± 3.68 vs. 108.61 ± 4.51, P = 0.004; FH:HV, 133.15 ± 3.68 vs. 108.61 ± 4.51, P = 0.003; RHV:HV, 142.67 ± 8.91 vs. 108.61 ± 4.51, P = 0.002). RHV patients presented higher compulsive factor score than FH (1.85 ± 0.16 vs. 1.58 ± 0.06, P = 0.047) and HV (1.85 ± 0.16 vs. 1.37 ± 0.09, P = 0.004). The patients of NERD, FH, and RHV presented significantly higher depression, anxiety, and hostile factor scores than those of HV (P < 0.05). Conclusions: NERD, RHV, and FH patients showed higher scores than HVs in total and most factors of SCL-90. Furtherly, RHV patients presented higher compulsive score than FH, NERD, and HVs. The role of senseless thought, impulse, and act of compulsive behavior in the pathogenesis of RHV needs to be studied furtherly.
